Radiation boosts immunotherapy in lung cancer fight

NCT ID NCT04245514

Ongoing Disease control Sponsor: Swiss Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding a special type of radiation to standard immunotherapy before surgery can help prevent lung cancer from coming back. About 90 people with stage III lung cancer that has spread to lymph nodes will receive chemotherapy, then immunotherapy plus radiation, followed by surgery. The goal is to see if this combination improves cancer control and survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER NSCLC

Contacts and locations

Locations

Hôpitaux Universitaires de Genève

Geneva, 1211, Switzerland
IOSI Ospedale Regionale di Bellinzona e Valli

Bellinzona, 6500, Switzerland
Inselspital

Bern, 3010, Switzerland
Kantonsspital - St. Gallen

Sankt Gallen, CH-9007, Switzerland
Kantonsspital Aarau

Aarau, CH-5001, Switzerland
Kantonsspital Baden

Baden, 5404, Switzerland
Kantonsspital Graubuenden

Chur, CH-7000, Switzerland
Regionalspital Thun

Thun, 3600, Switzerland
St. Claraspital Basel

Basel, 4016, Switzerland
Stadtspital Triemli

Zurich, 8063, Switzerland
Universitaetsspital Basel

Basel, 4031, Switzerland
Universitätsklinikum Tübingen

Tübingen, 72076, Germany
Universitätsspital Zuerich

Zurich, 8091, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.